A carregar...
Advances in preclinical approaches to Chagas disease drug discovery
INTRODUCTION: Chagas disease affects 8–10 million people worldwide, mainly in Latin America. The current therapy for Chagas disease is limited to nifurtimox and benznidazole, which are effective in treating only the acute phase of the disease but with severe side effects. Therefore, there is an unme...
Na minha lista:
| Publicado no: | Expert Opin Drug Discov |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6779130/ https://ncbi.nlm.nih.gov/pubmed/31411084 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17460441.2019.1652593 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|